Aggregating and Disaggregating Patients in Clinical Trials and Their Subgroup Analyses

被引：11
|
作者：
Kent, David M. [1 ]
Lindenauer, Peter K. [2 ]
机构：
[1] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
[2] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA
来源：
ANNALS OF INTERNAL MEDICINE | 2010年 / 153卷 / 01期
关键词：
D O I：
10.7326/0003-4819-153-1-201007060-00012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / W27
页数：3
相关论文
共 50 条
  • [1] Subgroup analyses in clinical trials - Reply
    Wang, Rui
    Lagakos, Stephen W.
    Drazen, Jeffrey M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (11): : 1199 - 1200
  • [2] Subgroup Analyses in Nephrology Clinical Trials
    Fishbane, Steven
    Shah, Hitesh H.
    Kataria, Ashish
    Shirazian, Shayan
    Agarwal, Rajiv
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (11): : 1872 - 1876
  • [3] On problems related to subgroup analyses in clinical trials
    Schmoor, C
    [J]. ONKOLOGIE, 2000, 23 (04): : 346 - 351
  • [4] More on subgroup analyses in clinical trials - Reply
    Wang, Rui
    Lagakos, Stephen W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (19): : 2076 - 2077
  • [5] CLINICAL-TRIALS - SUBGROUP ANALYSES - REPLY
    NOWAK, R
    [J]. SCIENCE, 1994, 265 (5176) : 1158 - 1158
  • [6] Issues in subgroup analyses and meta-analyses of clinical trials
    Bigger, JT
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (09) : S6 - S8
  • [7] Adjusted significance levels for subgroup analyses in clinical trials
    Spiessens, Bart
    Debois, Muriel
    [J]. CONTEMPORARY CLINICAL TRIALS, 2010, 31 (06) : 647 - 656
  • [8] A critical review of graphics for subgroup analyses in clinical trials
    Ballarini, Nicolas M.
    Chiu, Yi-Da
    Koenig, Franz
    Posch, Martin
    Jaki, Thomas
    [J]. PHARMACEUTICAL STATISTICS, 2020, 19 (05) : 541 - 560
  • [9] Reporting of subgroup analyses from clinical trials reply
    Kappos, Ludwig
    Devonshire, Virginia
    Haering, Dieter Adrian
    [J]. LANCET NEUROLOGY, 2012, 11 (09): : 747 - 748
  • [10] Interpretation of Subgroup Analyses in Medical Device Clinical Trials
    Pamela E. Scott
    Gregory Campbell
    [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 (1): : 213 - 220
12345